Serotonin syndrome and atypical antipsychotics.
Duggal
Harprret S
HS
Fetchko
Joseph
J
D000929:Antidepressive Agents, Tricyclic / Q000008:administration & dosage / Q000009:adverse effects*; D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001569:Benzodiazepines; D003865:Major Depressive Disorder / Q000188:drug therapy* / Q000235:genetics; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D006801:Humans; D008297:Male; D008803:Mianserin / Q000008:administration & dosage / Q000009:adverse effects* / Q000031:analogs & derivatives*; D008875:Middle Aged; D000078785:Mirtazapine; D000077152:Olanzapine; D010890:Pirenzepine / Q000008:administration & dosage / Q000009:adverse effects* / Q000031:analogs & derivatives*; D012559:Schizophrenia / Q000188:drug therapy* / Q000235:genetics; D012569:Schizotypal Personality Disorder / Q000188:drug therapy* / Q000235:genetics; D020230:Serotonin Syndrome / Q000175:diagnosis / Q000209:etiology*; D014147:Tramadol / Q000008:administration & dosage / Q000009:adverse effects*
D000929:Antidepressive Agents, Tricyclic; D014150:Antipsychotic Agents; D001569:Benzodiazepines; D008803:Mianserin; D014147:Tramadol; D010890:Pirenzepine; D000078785:Mirtazapine; D000077152:Olanzapine